BASDAI

Revision as of 22:41, 8 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for BASDAI

Articles

Most recent articles on BASDAI

Most cited articles on BASDAI

Review articles on BASDAI

Articles on BASDAI in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on BASDAI

Images of BASDAI

Photos of BASDAI

Podcasts & MP3s on BASDAI

Videos on BASDAI

Evidence Based Medicine

Cochrane Collaboration on BASDAI

Bandolier on BASDAI

TRIP on BASDAI

Clinical Trials

Ongoing Trials on BASDAI at Clinical Trials.gov

Trial results on BASDAI

Clinical Trials on BASDAI at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on BASDAI

NICE Guidance on BASDAI

NHS PRODIGY Guidance

FDA on BASDAI

CDC on BASDAI

Books

Books on BASDAI

News

BASDAI in the news

Be alerted to news on BASDAI

News trends on BASDAI

Commentary

Blogs on BASDAI

Definitions

Definitions of BASDAI

Patient Resources / Community

Patient resources on BASDAI

Discussion groups on BASDAI

Patient Handouts on BASDAI

Directions to Hospitals Treating BASDAI

Risk calculators and risk factors for BASDAI

Healthcare Provider Resources

Symptoms of BASDAI

Causes & Risk Factors for BASDAI

Diagnostic studies for BASDAI

Treatment of BASDAI

Continuing Medical Education (CME)

CME Programs on BASDAI

International

BASDAI en Espanol

BASDAI en Francais

Business

BASDAI in the Marketplace

Patents on BASDAI

Experimental / Informatics

List of terms related to BASDAI


Overview

The BASDAI is important because it is a validated diagnostic test which allows a physician (usually a rheumatologist) to determine the effectiveness of a current drug therapy, or the need to institute a new drug therapy for the treatment of ankylosing spondylitis. The BASDAI consists of a one through 10 scale (one being no problem and 10 being the worst problem) in response to 6 questions pertaining to the 5 major symptoms of AS:

  • Fatigue
  • Spinal pain
  • Joint pain / swelling
  • Areas of localized tenderness (also called enthesitis, or inflammation of tendons and ligaments)
  • Morning stiffness duration
  • Morning stiffness severity

To give each symptom equal weighting, the average of the two scores relating to morning stiffness is taken. The resulting 0 to 50 score is divided by 5 to give a final 0 – 10 BASDAI score. Scores of 4 or greater suggest suboptimal control of disease, and patients with scores of 4 or greater are usually good candidates for either a change in their medical therapy, eligible for treatment with powerful biologic therapies such as etanercept, infliximab and adalimumab, or may be eligible for enrollment in clinical trials evaluating new drug therapies directed at Ankylosing Spondylitis.

History

Garrett and coworkers writing in the Journal of Rheumatology in December 1994 described a self-administered 6-question measurement tool which was to become the gold standard for measuring and evaluating disease activity in Ankylosing Spondylitis (AS). This validated tool is the BASDAI, or the Bath Ankylosing Spondylitis Disease Activity Index. A research team consisting of rheumatologists, physiotherapists, and research associates with a special interest in AS developed the index in Bath, England, hence the reason for "Bath" in the name.

Validation

BASDAI is a quick and simple index (taking between 30 secs and 2 mins to complete) BASDAI demonstrated statistically significant (p<0.001) reliability. BASDAI encorporates a reasonable scale. The individual symptoms and the index as a whole demonstrated good score distribution, using 95% of the scale. BASDAI demonstrates a sensitivity to change within a short period of time. Following a 3 week physiotherapy course, the BASDAI showed a significant (p=0.009) 16.4% score improvement.

Tools and references


Template:WikiDoc Sources